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The Gompertz law of mortality quantitatively describes the mortality rate of humans and almost all
multicellular animals. However, its underlying kinetic mechanism is unclear. The Gompertz law cannot
explain the mortality plateau at advanced ages and cannot give an explicit relationship between tem-
perature and mortality. In this study a reaction kinetics model with a time dependent rate coefﬁcient is
proposed to describe the survival and senescence processes. A temperature-dependent mortality func-
tion was derived. The new mortality function becomes the Gompertz mortality function with the same
relationship of parameters prescribed by the Strehler–Mildvan correlation when age is smaller than a
characteristic value δ, and reaches the mortality plateau when age is greater than δ. A closed-form
analytical expression for describing the relationship of average lifespan with temperature and other
equations are derived from the new mortality function. The derived equations can be used to estimate
the limit of average lifespan, predict the maximal longevity, calculate the temperature coefﬁcient of
lifespan, and explain the tendency of the survival curve. This prediction is consistent with the most
recently reported mortality trajectories for single-year birth cohorts. This study suggests that the se-
nescence process results from the imbalance between damaging energy and protecting energy for the
critical chemical substance in the body. The rate of senescence of the organism increases while the
protecting energy decreases. The mortality plateau is reached when the protecting energy decreases to
its minimal levels. The decreasing rate of the protecting energy is temperature-dependent. This study is
exploring the connection between the biochemical mechanism and demography.
& 2015 The Author. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The human mortality rate closely ﬁts to an exponential formula
that was proposed by Benjamin Gompertz in 1825 [1]. This for-
mula is known today as the Gompertz “law of mortality”.
Searching for the mechanism underlying the mortality law started
in the 19 century [2]. It was suggested that changes in certain
substances and inherent energy were related to the aging process
[2–5]. Nearly a century ago, it was demonstrated that the ambient
temperature might change the lifespan of the aseptic ﬂies of
Drosophila [6] and that the temperature coefﬁcient for Drosophi-
la's lifespan is close to that of a chemical reaction, indicating that
chemical substances play an important role in the aging process. A
few years later, Brownlee conjectured that the inherent energy of
certain substances in the body is gradually being destroyed
throughout life [3]. However, in the same paper, he also pointedB.V. This is an open access article
The FASEB Journal vol. 28 no.
dicine, The Ohio State Uni-
mbus, OH 43210, USA.out “Various formulas in physical chemistry, which might be
considered possibly applicable, were tried without success”. Up to
now, it is unclear whether Brownlee's conjecture is correct or not.
Furthermore, lines of evidence show that the real mortality rate at
very advanced ages levels off from the exponential formula of
mortality rate (deviation from the Gompertz law of mortality) [7],
and the Gompertz law of mortality cannot be used to predict the
effect of temperature on lifespan because temperature is not a
variable or parameter in the Gompertz function. Different types of
mortality models have been developed to describe the late-life
mortality trajectories. A summary of these models and recent
contributions in the area of data-driven modeling of mortality can
be found in the references [8–10]. In this study, the author will
explore the following questions: What is the biochemical me-
chanism underlying Gompertz's law of mortality? Why does a
mortality rate plateau exist at very advanced ages? How can the
effect of temperature on lifespan be explained? A new mortality
rate function will be presented. This new mortality function pre-
dicts the mortality plateau appearing in the period of age greater
than δ, consistent with human mortality data demonstrated in a
recent article [11]. Analytical expressions for describing the re-
lationship of average lifespan with temperature and some other
equations will be derived from this new function.under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Considering that a molecule has an initial concentration c0 and
its decomposition rate (dc/dx) follows ﬁrst-order kinetics as below:
dc x
dx
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where c is the concentration of the molecules at time x, k is the
rate constant, Ea is the activation energy for the decomposition
reaction, k′ is the pre-exponential factor, R is the gas constant, T is
the absolute temperature, and N is the number of molecules at
time x (N0 is the initial number of the molecules). The above two
equations can be converted to each other by a factor of the volume
V containing these molecules. Assuming that the life process is a
chemical process and that a large number of people (s0) with
identical biological and chemical properties are born on the same
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wherem is the rate coefﬁcient, A is the pre-exponential factor, and
El is the activation energy relating to the rate of decrease of the
survival function s. El can be also considered as the living energy
that is required for survival. Unlike the normal simple molecules,
humans will age and their death rate varies with age, so m is a
function of x.
Hypothesis: The living energy El, which is proportional to the
quantity of a vital molecular unit that linearly decreases with time,
is the energy to protect the chemical substance that is critical for
life from being impaired by damaging energy (the magnitudes of
challenges [4]) from other molecules or from itself. This hypothesis
suggests that aging results from the imbalance between damaging
energy and protecting energy for the critical chemical substance.
The rate of senescence of the organism increases as the protecting
energy decreases.
Under this hypothesis, we assume that the initial quantity of
this vital molecular unit is l0 and its rate of decrease is b. At time x,
the quantity (L) of this molecular unit is:
L x l bx 30( ) = − ( )
The identity of this vital molecular unit is unclear. Telomeres,
which protect DNA (the critical chemical substance) from de-
gradation, may be one of the candidates. It has been shown that
the length of the shortest telomeres is the major determinant of
the onset of senescence [12,13]. Since the average length of telo-
meres and the shortest 5% of telomeres are shortened at a rate
nearly linear with time [14,15], we can assume that the length of
the shortest telomeres (such as the shortest 5% [15]) also decreases
linearly with time. In this case, L, l0 and b can be considered as the
length of the shortest telomeres at time x, the initial length of the
shortest telomeres, and the shortening rate of telomeres. Based on
the above hypothesis, the living energy El is proportional to L:
E x k L x k l bx 4l 0 0 0( )( ) = ( ) = − ( )
where k0 is the coefﬁcient for converting the length of telo-
meres into the living energy. Eq. (4) deﬁnes the conversion re-
lationship from the vital molecular unit to the living energy. In the
real world, a person's death is usually caused by some diseases
[16]. The diseases may be prevented by some medicines, physical
exercise, and good personal hygiene. If a person becomes ill with a
disease, the disease may be medically treated. As a result, these
external “forces” can enlarge or reduce the living energy. There-
fore, k0 has included the effect of these external “forces”.In Eq. (4), b is a rate constant of telomere shortening, so it can
be written in the following form based on the Arrhenius equation:
b b e 5E RT0 /t= ( )−
where Et is the activation energy independent of time x in the
telomere shortening process.
Eq. (4) can be written as:
E x k l bx x e x 6l E RT0 0 0 /tβ α β α( ) = ( − ) = ′ − ′ = ′ − ( ′ ) ( )−
where β′¼k0l0 and
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Since the effective length of the telomere cannot be less than 0,
we have:
l bx E x0 or 0 8l0 β α− ≥ = ′ − ′ ≥ ( )
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At x¼δ, El becomes zero and m(x) becomes the constant A. In
this situation, m(x) is no longer dependent on time x because the
effective telomere length or the living energy has dropped to zero
already. So m(x) will remain at the constant A as x continuously
increases:
m x A x, for 9δ( ) = ≥ ( ′)
In Eq. (9), β¼β′/RT and
RT RT e k b RT e/ / / 10E RT E RT0 / 0 0 /t tα α α= ′ = ( ′ ) = ( ) ( )− −
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Based on the deﬁnition of mortality rate, m(x) is the mortality
rate. Substitution of Eqs. (9) and (9′) into (2) gives:
ds x
dx
m x s x Ae s x x, for 12
x δ( ) = − ( ) ( ) = − ( ) ≤ ( )
α δ( − )
ds x
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Solving the differential Eqs. (12) and (12′), we can derive the
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In many cases, such as for human survival functions, αδ»1, so
(A/α)exp(αδ) is close to 0 or the parameter B is close to one.
Thus, B can be omitted in the following derivation of equations.
Eq. (13) has the same form as the Gompertz survival function.
When xZδ, the decay rate of S(x) follows ﬁrst order kinetics (Eq.
(13′)). The decay rate constant is A and the half-life t1/2 of S(x) at
very advanced ages can be calculated from the following half-life
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characteristic value representing the average time that a human
body uses up all its living energy. Therefore, δ can be looked at as
the characteristic value for life. Eq. (9) can be rewritten in the
form: m(x)¼R exp(αx), where R¼A exp(αδ), or
R Aln ln 16αδ( ) = ( ) − ( )
Eq. (13) is the same as the SM correlation (linear relationship
between ln(R) and α) derived by Strehler and Mildvan if the
symbols R, A and δ in Eq. (16) here are replaced by R0, K and 1/B in
Eq. (16) in SM's paper [4], respectively. Taking logarithms on both
sides of Eq. (9), we have
m x A x A x xln ln ln , for 16α δ αδ α δ( ( )) = ( ) + ( − ) = ( ( ) − ) + ≤ ( ′)
Taking logarithms on both sides of Eq. (9′), we have
ln m x ln A x, for 16δ( ( )) = ( ) ≥ ( ′′)
Eq. (16′) shows that the plot of ln(m(x)) vs. x is a straight line
with a slope of α and the intercept of ln(A)αδ. At x¼δ, all plots
of ln(m(x)) vs. x will intersect at the point (δ, lnA) regardless of the
value of α if both A and δ are constants. Eq. (16′) is known as the
compensation law of mortality [17]. The mortality plateau will
appear when xZδ as described by Eq. (16′′).3. Results
3.1. Finding the life characteristic value δ
Eq. (13) was used to ﬁt survival curves of 11 countries around
the world (data were obtained from the Human Life-Table Data-
base and the Human Mortality Database [18,19]) for the past 100–
200 years. Since the data points are not stable at younger ages, we
used data points forZ40 years of ages in the curve-ﬁtting analysis.
The parameters B, α and x0 were determined from the lines of best
ﬁt. These lines of best ﬁt, including all lines of best ﬁt in the Results
section, were obtained by the linear regression method in Sig-
maPlot. These determined parameters were used to further cal-
culate the parameter δ from Eq. (14). The determined values of x0
and the calculated values of the parameter δ for the 11 countries
(males) are plotted in Fig. 1. These data show that x0 (x0 is pro-
portional to the life expectancy at birth) increased linearly in theFig. 1. Determination of parameters x0 and δ. Values of x0 are determined from the
survival data of 11 countries (male) (Australia, Canada, Denmark, France, Germany,
Japan, Netherlands, Norway, Sweden, Scotland and USA) for the past 100–200
years. The plotted data points show that x0 (●) linearly increases in the past 200
years, but δ (▲) is almost independent of time.past 200 years, but δ is almost a constant (100.472.0 years) in the
same period. The average value of δ between 1820 and 1900 is
101.371.4 years. It slightly decreased in the period from 1900 to
1940 and increased from 1960 to the present. The average value of
δ between 1940 and 1960 is 99.071.6 years, but it increases to
102.571.9 years between 2000 and 2011.3.2. Mortality plateau at very advanced ages
An examination of the mortality rate in the United States from
1999 to 2007 shows that the plot of the logarithm of the mortality
rate vs. age (x) for ages greater than 80 years old for each of these
8 years is similar. The logarithm of the mortality rate reaches a
plateau at age 104 (Fig. 2A). The mortality rate plateau was also
seen in other animals [20]. However, the mortality plateau or
deceleration at old age was not clearly seen in a number of studies
on mammals [17,21,22]. In a recent paper, Gavrilova and Gavrilov
showed that the logarithms of mortality rates for 1895 and 1898
birth cohorts of U.S. women linearly rose with age up to very ad-
vanced ages [11]. Based on their data, they suggested that mor-
tality deceleration at advanced ages is not a universal phenom-
enon, and the survival of the mammalian species follows the
Gompertz law up to very old ages. Thus, one may ask: is there no
mortality plateau at all, or is there a mortality plateau that appears
at very advanced ages that was not shown in some of earlier
studies? Their data are very helpful to answer the above question.
To compare the two mortality trajectories, we read the data points
from their paper and re-plotted these data points in Fig. 2B and C.
The two linear plots intersect at a very advanced age (Fig. 2B). To
determine the intersection point, we re-plotted the two sets of
mortality data in Fig. 2C, but only the data with ages greater than
80 are shown. The solid lines are the lines of best ﬁt for the data
points (1895 and 1898 birth cohorts) between 80 and 90 years. The
two ﬁtting lines intersect at the point (104.2, 0.495) designated
by the red star. The dashed line is the mortality plateau predicted
from Eq. (16′′) for the 1898 birth cohort.3.3. Effect of temperature on survival
The average lifespan or the life expectancy at birth (LE0) can be
calculated from Eqs. (13) and (13′):
LE S x dx e dx
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If the mortality plateau occurs at the tail part of a survival curve
(such as human survival curve (Fig. 2)) or the difference of the last
two terms in the right side of Eq. (17) is small enough compared to
the ﬁrst term, then the last two term can be ignored. Under this
approximation, LE0 can be approximately expressed by the ﬁrst
term in Eq. (17). Let y¼α(xx0), dy¼αdx. Eq. (17) can be rewritten
as:
















For αx0Z2, Eq. (18) can be approximately expressed as:
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where the constant 0.577 is the Euler–Mascheroni constant [23].
Combining Eq. (14) with (19) gives:
Fig. 2. Mortality rate at advanced ages. A: Mortality trajectory survival data points (▼) were obtained from 2006 U.S. real death data for the total population. The dashed line
was calculated by assuming α¼0.094 1/year, δ¼103.7 year, and ln(A)¼0.445. B: Mortality trajectories for two single-year birth cohorts of U.S. women (data points were
read from the published paper [11]). C: Mortality data sets are the same as those in B, but only the data with ages greater than 80 are shown. The solid lines are the best-
ﬁtting lines for the data points (1895 and 1898 birth cohorts) between 80 and 90 years. The two ﬁtting lines intersect at the point (104.2, 0.495) designated by the red star.
The dashed line is the mortality plateau predicted from Eq. (16′′) for the 1898 birth cohort.
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where Q¼(β ln(A/α)0.577). When T varies 715 °C around
25 °C (298715 K), the change in ln(Q) is relatively small. Applying
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where g QRln ln /1 0α( ) = ( ′) is close to a constant independent of T,
and g2¼Et/R. Eq. (21) is similar to the empirical formula proposed
by Shaw et al. [5].
Taking the derivative of both sides of Eq. (21) with respect to T
and considering that g2/T»1 (based on published experimental data
[24,25]), we can obtain the equation for the temperature coefﬁ-
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The negative sign indicates that LE0 decreases as T increases. Eq.
(22) shows that θ of a species is proportional to the activation
energy and LE0 of the species and inversely proportional to T
squared.
To test Eq. (21), we examined literature data regarding the ef-
fects of temperature on LE0 of poikilotherms such as ﬂies. The
results show that ln(LE0/T) (▲, Drosophila [24]; ●, Calliphora stygia
[25]) is linear with 1/T. From the slope of the lines of best ﬁt (solid
lines in Fig. 3A and B), we can determine the value of g2, which isFig. 3. Effect of ambient temperature on the lifespclose to 10,000 (K). Assuming T¼293 K (20 °C) and g2 is 10,000 K,
the calculated temperature coefﬁcient from Eq. (22) is
θE0.12LE0. This indicates that the lifespan will increase
0.12LE0 when the temperature decreases by one degree and will
double the average lifespan when the temperature decreases by
eight degrees.4. Discussion
Based on the hypothesis on the living energy and the vital
molecular unit, the author derived a new mortality rate equation.
This new equation has two branches (Eqs. (9) and (9′)) which are
divided by the characteristic value for life, δ. At xrδ, the equation
has the same form as the Gompertz mortality rate equation and
leads to the same parameter relationship (Eq. (16)) as the one
described by the Strehler–Mildvan correlation. However, the new
mortality rate equation contains two new terms. One is the mor-
tality rate in the xZδ branch (Eq. (9′)) that predicts the mortality
plateau at very advanced ages, and the other is the temperature-
dependent parameter (Eqs. (10) and (11)) describing the tem-
perature dependence of the mortality rate function. In addition to
Eq. (16), several other equations have been derived from Eq. (9).
The derived Eq. (14) gives the relationship between δ and other
parameters that can be obtained from the survival (x0 and α) and
mortality (A) curves. The values of x0 determined from survival
curves of 11 countries and the values of δ calculated from Eq. (14)
are demonstrated in Fig. 1. It can be seen that x0 gradually in-
creases during the period in the past centuries, but δ is close to a
constant (100.472.0 years) with a slight but continuous increasean of ﬂies. A: Drosophila; B: Calliphora stygia.
Fig. 4. Period patterns of survival improvement in Norway.
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stant, α will increase based on Eq. (14). In this case, the upper part
of the survival curve expressed by Eq. (9) will shift to the right side
quicker than the lower tail part. This tendency of change in x0 and
δ is consistent with the tendency (rectangularization [26,27]) of
change in the patterns of human survival curves in the past cen-
turies. An example of Norway survival curves is shown in Fig. 4.
This rectangularization is also a result described by Strehler and
Mildvan theory of mortality because the theory assumed that δ (or
1/B) is a constant [4]. However, analysis of the survival data of the
last century shows that this process continued with a slight ten-
dency to derectangularization of the survival curves in the de-
veloped countries after 1950–1960 [28]. This derectangularization
deviates from the Strehler and Mildvan theory of mortality. In
contrast, the value of δ is not required as a constant in the new
mortality equation presented above, because δ is dependent on
body temperature. It is interesting that this derectangularization
process occurs with the increase in δ in the same period (after
1950–1960), implying that the derectangularization may be
caused by the reduction in average body temperature due to the
improvement of living and working conditions during this period.
The new mortality rate equation shows that the age-dependent
rate coefﬁcient or mortality rate increases exponentially with age
until age reaches the characteristic value of life, δ. As xZδ, ln(m
(x)) is a constant, ln(A) (Fig. 2). This type of mortality rate can be
seen in some organisms such as seed beetle species [29,30]. It was
also demonstrated that the logarithm of mortality rate is linear
with age up to very advanced ages when mortality data of single-
year birth cohorts are used [11]. The mortality trajectories for 1895
birth cohort and 1898 birth cohort of U.S. women intersect at 104
years of age (Fig. 2B and C). From Eqs. (16′) and (16′′), we know
that the value of x at the intersection is equal to δ, and the mor-
tality plateau (the value of y at the intersection) will appear when
the age x is greater than δ. It is interesting to note that the mor-
tality plateau does show up for the 1898 birth cohort after 104
years of age, and there is no plateau in the mortality curve for the
1895 birth cohort before 104 years of age. Thus, mortality trajec-
tories shown in Fig. 2B and C are an excellent example for the new
mortality function (Eqs. (16′) and (16′′)). To see a mortality plateau
for humans, the initial sample size needs to be large enough to
ensure there are enough samples at very advanced ages. Further-
more, human health needs to improve so that more people can
survive to very advanced ages. As more and more people survive
to ages over 100 years, the mortality plateau will be more easily
observed from mortality curves.
The derived Eq. (20) gives the relationship between LE0 and theparameters in survival and mortality functions (α, δ and A). Eq.
(20) shows that LE0 approaches δ, as α approaches inﬁnity. The
average δ in the past 200 years for the male population is nearly
constant (101 years), indicating that the ratio of l0 to b (the time
it takes to use up the living energy) did not signiﬁcantly increase.
Therefore, based on Eq. (20), the LE0 increase in the past 200 years
was mainly caused by α relating to those external “forces”, such as
improvement in health and medical services, which contributed to
k0 for enlarging the living energy. This indicates that the maximal
LE0 will be limited by the characteristic value of life δ if biomedical
technology in the future can only increase α but is not able to
extend δ (δ ranges from 102 to 105 years between 2004 and 2011).
The mortality will reach its maximal rate at age δ, implying that
the mortality will not increase exponentially with age, but will
remain in a constant A after age δ. As a result, the mortality rate for
human with ages greater than δ is signiﬁcantly slower than that
predicted by Gompertz mortality law. Despite this slow mortality
rate, if there are 10,000 people at 105 years of age, only one of
them may be alive at 120 assuming A¼0.64. Therefore, the prob-
ability of living up to 120 years for a human being is extremely low
[31], if δ is not extended.
To signiﬁcantly increase maximal human lifespan, δ needs to be
elongated and/or the life decay rate constant A needs to decrease.
The life decay is likely a characteristic of the human body. It may
not be cured by modern medicine at this point [32]. Since δ is the
ratio of the initial quantity of this vital molecular unit (l0) and its
decrease rate (b), the increase in δ implies the decrease in b if we
assume that l0 does not change in humans. Decrease in b can be
reached through either physical methods (such as room tem-
perature) or biochemical methods. It is interesting that the average
δ value has been slowly increasing in the past 50 years from its
minimum (1940–1960). From Eq. (5) we know that decrease in b
can be caused by the decrease in body temperature, and the de-
crease in body temperature may be related to the continuous
improvement of working and living conditions (such as the broad
application of air conditioners in the developed countries). A line
of evidence has shown that temperature reduction in both poiki-
lotherms and homeotherms extends lifespan [33-40] [34–41]. It
was observed that when Drosophila ﬂies were switched from 27 °C
to 18 °C environments at various adult ages, the increased mor-
tality driven by life at a higher temperature persisted in the
switched ﬂies compared to the 18 °C control ﬂies [39,40], but the
subsequent rate of increase in mortality with age at 18 °C was
lower than in the ﬂies permanently at 27 °C. To test if the new
mortality equation can explain the effect of temperature on life-
span, a simple expression, Eq. (21), for describing the relationship
between the average lifespan (LE0) and body temperature was
derived from the new mortality rate equation. This expression is
similar to the empirical formula proposed by Shaw et al. [5]. As
shown in Fig. 3, the linear relationship of ln(LE0/T) with 1/T is
consistent with published experimental data.
Humans are homeothermic with a core body temperature at
37 °C. Usually, a living person's body temperature is not uniform
[41]. Research has shown that when room temperature changes
from 35 °C to 15 °C, core body temperature can decrease by
0.7 °C, and the change in skin temperature is relatively larger
[42]. Thus, the change in average body temperature should be
greater than 0.7 °C when room temperature varies from 35 °C to
15 °C. While humans can normally live at ambient temperature
between 15 °C and 35 °C without largely life-threatening risk if
they have enough water, food, clothes, and suitable medical ser-
vices, their average body temperature may have 1 °C difference
between the people living in a place with an average temperature
of 35 °C and the people living in another place with an average
temperature of 15 °C. Provided that the LE0 for humans is 75 years
and the temperature coefﬁcient for humans is close to
X. Liu / Biochemistry and Biophysics Reports 4 (2015) 228–233 233poikilotherms (0.12LE0), the 1 °C difference in body temperature
will result in 9 years (0.1275¼9) difference in average lifespan
under health cold conditions. Health cold conditions are important
for extending lifespan because it was demonstrated that un-
protected long time cold-exposed rats had greater incidence of
some diseases and died from these diseases [43].5. Conclusions
The author proposed a new mortality rate function. This mortality
equation can explain the mortality plateau at advanced age and the
effect of temperature on lifespan. Several closed-form analytical ex-
pressions have been derived from the new mortality function. Eq. (14)
provides a method for determining δ. The determined δ from 11 de-
veloped countries is near a constant in the past centuries, but shows a
continuous increase after 1950–1960. This continuous increase in δ in
the past 50–60 years is consistent with the derectangularization of
survival curves in the developed countries in the same period. The
derived Eqs. (16) and (16′) have the same forms to the related equa-
tions from the Strehler and Mildvan theory of mortality for age xrδ.
The mortality plateau, as described in Eq. (16′′), appears when xZδ.
This indicates that the newmortality rate function cannot only explain
the mortality and survival data for xZδ as demonstrated in Fig. 2, but
also is consistent with the previous well-known mortality rate equa-
tions for xrδ. The derived Eq. (21) deﬁnes a linear relationship be-
tween ln(LE0) and 1/T, which is validated by published experimental
data. The derived Eq. (22) is the closed-form expression for tem-
perature coefﬁcient of average lifespan.Acknowledgments
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